\-\ Texto\\:\\ \ \(0\)\
\-\ n\\/a\ \(127\)\
\-\ treatment\\ largely\\ depends\\ on\\ the\\ nature\\ and\\ severity\\ of\\ the\\ clinical\\ presentation\\.\\ \\ nonsteroidal\\ anti\\-inflammatory\\ drugs\\ \\(nsaids\\)\\ and\\ local\\ heat\\ application\\ and\\ range\\-of\\-motion\\ exercises\\ are\\ core\\ treatments\\.\\ \\ local\\ corticosteroid\\ injections\\ may\\ be\\ beneficial\\.\\ \\ needle\\ aspiration\\ or\\ surgical\\ removal\\ of\\ the\\ deposit\\ may\\ be\\ appropriate\\ in\\ patients\\ unresponsive\\ to\\ other\\ treatments\\.\ \(0\)\
\-\ ap\\ radiograph\\ of\\ the\\ left\\ shoulder\\ reveals\\ large\\ calcific\\ deposits\\ in\\ the\\ region\\ of\\ the\\ distal\\ supraspinatus\\ tendon\\,\\ the\\ most\\ common\\ site\\ of\\ hydroxyapatite\\ deposition\\.\ \(0\)\
\-\ ap\\ radiograph\\ of\\ the\\ left\\ hip\\ demonstrate\\ calcific\\ deposits\\ adjacent\\ to\\ greater\\ trochanter\\ of\\ the\\ femur\\ in\\ the\\ region\\ of\\ the\\ gluteus\\ medius\\ consistent\\ with\\ hydroxyapatite\\ deposition\\ disease\ \(0\)\
\-\ hydroxyapatite\\ deposition\\ disease\ \(2\)\
\-\ diagnosis\\ confirmed\\ by\\:\\ radiographic\\ findings\\ and\\ clinical\\ evaluation\ \(0\)\
\-\ hydroxyapatite\\ deposition\\ disease\\ \\(hadd\\)\\ associated\\ with\\:\\ \ \(0\)\
\-\ \\	hyperparathyroidism\ \(0\)\
\-\ \\	hypoparathyroidism\ \(0\)\
\-\ \\	tumoral\\ calcinosis\ \(0\)\
\-\ \\	connective\\ tissue\\ disease\ \(0\)\
\-\ \\	hypervitaminosis\\ d\ \(0\)\
\-\ \\	calcium\\ pyrophosphate\\ deposition\\ disease\\ \\(cppd\\)\ \(0\)\
\-\ \\	gout\ \(0\)\
\-\ \\	sarcoidosis\ \(0\)\
\-\ 35\\-year\\-old\\ female\\ presented\\ with\\ a\\ 10\\ year\\ history\\ of\\ shoulder\\ and\\ left\\ hip\\ pain\\.\\ \\ pain\\ was\\ worse\\ with\\ abduction\\ and\\ had\\ increased\\ substantially\\ over\\ the\\ past\\ year\\.\ \(0\)\
\-\ hydroxyapatite\\ deposition\\ disease\\ \\(hadd\\)\\ is\\ an\\ idiopathic\\ disorder\\ characterized\\ by\\ intra\\-\\ and\\/or\\ peri\\-articular\\ deposits\\ of\\ calcium\\ hydroxyapatite\\ crystals\\,\\ especially\\ in\\ or\\ around\\ the\\ tendons\\.\\ \\ the\\ shoulder\\ is\\ the\\ most\\ commonly\\ affected\\ joint\\ with\\ the\\ deposition\\ often\\ occurring\\ within\\ the\\ supraspinatus\\ tendon\\ and\\ other\\ tendons\\ of\\ the\\ rotator\\ cuff\\.\\ \\ other\\ common\\ sites\\ include\\ the\\ hip\\,\\ knee\\,\\ elbow\\ and\\ facet\\ joints\\ and\\ bursae\\ of\\ the\\ lumbar\\ spine\\,\\ though\\ hadd\\ can\\ affect\\ most\\ joints\\.\\ \\ the\\ deposits\\ are\\ often\\ monoarticular\\ in\\ distribution\\.\\ \\ \ \(0\)\
\-\ hadd\\ occurs\\ in\\ up\\ to\\ 3\\%\\ of\\ adults\\ between\\ the\\ ages\\ of\\ 40\\ and\\ 70\\ years\\ with\\ a\\ slightly\\ higher\\ frequency\\ in\\ men\\ than\\ women\\.\\ \\ clinically\\,\\ hadd\\ is\\ characterized\\ by\\ recurrent\\ episodes\\ of\\ pain\\,\\ swelling\\,\\ erythema\\,\\ and\\ tenderness\\ around\\ the\\ affected\\ joint\\.\\ \\ there\\ may\\ be\\ a\\ varying\\ degree\\ of\\ disability\\.\\ \\ some\\ patients\\ may\\ by\\ asymptomatic\\.\\ \\ \\ \ \(0\)\
\-\ the\\ natural\\ history\\ of\\ hadd\\ is\\ progressive\\,\\ although\\ all\\ stages\\ may\\ not\\ be\\ apparent\\.\\ \\ an\\ initial\\,\\ silent\\ stage\\ is\\ characterized\\ by\\ calcific\\ deposits\\ in\\ the\\ tendons\\.\\ \\ during\\ this\\ time\\ the\\ patient\\ is\\ often\\ asymptomatic\\.\\ \\ as\\ the\\ deposits\\ collect\\ they\\ increase\\ in\\ size\\ and\\ the\\ disease\\ enters\\ a\\ mechanical\\ stage\\ whereby\\ the\\ deposits\\ may\\ rupture\\ with\\ subbursal\\ or\\ intrabursal\\ extravasion\\ and\\ the\\ patient\\ may\\ experience\\ an\\ acute\\ painful\\ inflammatory\\ reaction\\ and\\ painful\\ attack\\.\\ \\ in\\ some\\ cases\\ the\\ inflammation\\ can\\ lead\\ to\\ bone\\ erosion\\,\\ adhesive\\ bursitis\\,\\ and\\/or\\ joint\\ destruction\\.\\ \\ however\\ in\\ other\\ patients\\ the\\ disease\\ has\\ resolved\\ spontaneously\\ or\\ following\\ treatment\\ with\\ nsaids\ \(0\)\
\-\ radiographically\\,\\ the\\ features\\ of\\ hydroxyapatite\\ deposits\\ depend\\ on\\ the\\ stage\\ of\\ involvement\\.\\ \\ initially\\ they\\ may\\ appear\\ as\\ amorphous\\,\\ cloud\\-like\\ densities\\.\\ \\ over\\ time\\ deposits\\ may\\ become\\ denser\\ with\\ more\\ delineated\\ borders\\ and\\ a\\ linear\\ or\\ ovoid\\ configuration\\.\\ \\ a\\ useful\\ distinguishing\\ characteristic\\ of\\ hadd\\ is\\ the\\ globular\\ appearance\\ of\\ calcium\\ deposition\\ in\\ or\\ around\\ the\\ tendons\\,\\ as\\ opposed\\ to\\ the\\ linear\\ configuration\\ of\\ calcium\\ deposition\\ in\\ within\\ the\\ cartilage\\ and\\ menisci\\ associated\\ with\\ calcium\\ pyrophosphate\\ deposition\\ disease\\.\\ \\ the\\ location\\ of\\ deposition\\ is\\ also\\ a\\ useful\\ indicator\\ of\\ hadd\\ with\\ the\\ most\\ common\\ sites\\ of\\ deposition\\ involving\\ the\\ shoulder\\ and\\ hip\\.\\ \\ \ \(0\)\
\-\ resources\\:\\ resnick\\,\\ d\\.\\ niwayama\\ g\\.\\ calcium\\ hydroxyapatite\\ deposition\\ disease\\.\\ in\\ resnick\\,\\ d\\,\\ ed\\.\\ diagnosis\\ of\\ bone\\ and\\ joint\\ disorders\\.\\ \\ 4th\\ ed\\.\\ philidelphia\\:\\ saunders\\,\\ 2002\\;\\ 1619\\-1654\\.\ \(0\)\
\-\ bonavita\\,\\ ja\\,\\ murray\\,\\ k\\,\\ et\\ al\\.\\ hydroxyapatite\\ deposition\\ disease\\.\\ \\ radiology\\ 1980\\;\\ 134\\:\\ 621\\-625\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ deposition\\:\\ 0\\.41709142775323715\ \(0\)\
\-\ hydroxyapatite\\:\\ 0\\.34153288931437187\ \(0\)\
\-\ hadd\\:\\ 0\\.325905959909246\ \(0\)\
\-\ deposits\\:\\ 0\\.30205811733253146\ \(0\)\
\-\ the\\:\\ 0\\.24157604089018178\ \(0\)\
\-\ calcium\\:\\ 0\\.16002480700254157\ \(0\)\
\-\ of\\:\\ 0\\.1560245710394916\ \(0\)\
\-\ disease\\:\\ 0\\.13634731689217303\ \(0\)\
\-\ may\\:\\ 0\\.13373915823399757\ \(0\)\
\-\ tendons\\:\\ 0\\.1273868955762777\ \(0\)\
\-\ and\\:\\ 0\\.1220359833282232\ \(0\)\
\-\ in\\:\\ 0\\.10284187537409206\ \(0\)\
\-\ calcific\\:\\ 0\\.0933178626071985\ \(0\)\
\-\ shoulder\\:\\ 0\\.0917528550210911\ \(0\)\
\-\ hip\\:\\ 0\\.09073355073735061\ \(0\)\
\-\ or\\:\\ 0\\.08218080991162527\ \(0\)\
\-\ characterized\\:\\ 0\\.08139032197826328\ \(0\)\
\-\ joint\\:\\ 0\\.07783228639661247\ \(0\)\
\-\ resnick\\:\\ 0\\.07169837103718991\ \(0\)\
\-\ around\\:\\ 0\\.0707062309289302\ \(0\)\
\-\ stage\\:\\ 0\\.07054612980606019\ \(0\)\
\-\ pyrophosphate\\:\\ 0\\.06916059022417927\ \(0\)\
\-\ is\\:\\ 0\\.06469366223425957\ \(0\)\
\-\ with\\:\\ 0\\.06360354638957778\ \(0\)\
\-\ supraspinatus\\:\\ 0\\.06317568419028896\ \(0\)\
\-\ by\\:\\ 0\\.06269855643944139\ \(0\)\
\-\ most\\:\\ 0\\.06147107097649295\ \(0\)\
\-\ other\\:\\ 0\\.061339463148914246\ \(0\)\
\-\ treatments\\:\\ 0\\.061121098948860204\ \(0\)\
\-\ configuration\\:\\ 0\\.05958448967903388\ \(0\)\
\-\ often\\:\\ 0\\.05780294408287357\ \(0\)\
\-\ nsaids\\:\\ 0\\.05778653168424539\ \(0\)\
\-\ sites\\:\\ 0\\.05763756344150497\ \(0\)\
\-\ useful\\:\\ 0\\.056385327247136394\ \(0\)\
\-\ painful\\:\\ 0\\.052231277105735364\ \(0\)\
\-\ tendon\\:\\ 0\\.051552140945735965\ \(0\)\
\-\ local\\:\\ 0\\.050837849864865135\ \(0\)\
\-\ joints\\:\\ 0\\.050761442770842984\ \(0\)\
\-\ common\\:\\ 0\\.0502389168735423\ \(0\)\
\-\ patients\\:\\ 0\\.04983497383183933\ \(0\)\
\-\ affected\\:\\ 0\\.04857373558225421\ \(0\)\
\-\ be\\:\\ 0\\.04791488294415993\ \(0\)\
\-\ linear\\:\\ 0\\.047575779791308496\ \(0\)\
\-\ ed\\:\\ 0\\.047245333201223476\ \(0\)\
\-\ subbursal\\:\\ 0\\.04722324405852882\ \(0\)\
\-\ intrabursal\\:\\ 0\\.04722324405852882\ \(0\)\
\-\ extravasion\\:\\ 0\\.04722324405852882\ \(0\)\
\-\ niwayama\\:\\ 0\\.04722324405852882\ \(0\)\
\-\ bonavita\\:\\ 0\\.04722324405852882\ \(0\)\
\-\ murray\\:\\ 0\\.04722324405852882\ \(0\)\
\-\ philidelphia\\:\\ 0\\.04512433076441579\ \(0\)\
\-\ collect\\:\\ 0\\.04363512808267492\ \(0\)\
\-\ ap\\:\\ 0\\.04239967870566147\ \(0\)\
\-\ they\\:\\ 0\\.04219798828338618\ \(0\)\
\-\ bursae\\:\\ 0\\.04153621478856189\ \(0\)\
\-\ monoarticular\\:\\ 0\\.04153621478856189\ \(0\)\
\-\ whereby\\:\\ 0\\.04073824498865575\ \(0\)\
\-\ 1980\\:\\ 0\\.04073824498865575\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.04020550789004896\ \(0\)\
\-\ nonsteroidal\\:\\ 0\\.04004701210682102\ \(0\)\
\-\ hypoparathyroidism\\:\\ 0\\.04004701210682102\ \(0\)\
\-\ hypervitaminosis\\:\\ 0\\.04004701210682102\ \(0\)\
\-\ substantially\\:\\ 0\\.04004701210682102\ \(0\)\
\-\ resources\\:\\ 0\\.04004701210682102\ \(0\)\
\-\ inflammatory\\:\\ 0\\.03993446847777861\ \(0\)\
\-\ medius\\:\\ 0\\.03943730149444886\ \(0\)\
\-\ denser\\:\\ 0\\.03943730149444886\ \(0\)\
\-\ globular\\:\\ 0\\.03943730149444886\ \(0\)\
\-\ calcinosis\\:\\ 0\\.038891896766479465\ \(0\)\
\-\ enters\\:\\ 0\\.038891896766479465\ \(0\)\
\-\ radiograph\\:\\ 0\\.03846542100317534\ \(0\)\
\-\ deposit\\:\\ 0\\.038398518176176115\ \(0\)\
\-\ gluteus\\:\\ 0\\.038398518176176115\ \(0\)\
\-\ delineated\\:\\ 0\\.038398518176176115\ \(0\)\
\-\ indicator\\:\\ 0\\.038398518176176115\ \(0\)\
\-\ trochanter\\:\\ 0\\.037948098812707984\ \(0\)\
\-\ silent\\:\\ 0\\.037948098812707984\ \(0\)\
\-\ adhesive\\:\\ 0\\.037948098812707984\ \(0\)\
\-\ ja\\:\\ 0\\.037948098812707984\ \(0\)\
\-\ 134\\:\\ 0\\.03753375316403636\ \(0\)\
\-\ clinical\\:\\ 0\\.03742814018794264\ \(0\)\
\-\ some\\:\\ 0\\.03715867455605823\ \(0\)\
\-\ tumoral\\:\\ 0\\.03715012901280185\ \(0\)\
\-\ to\\:\\ 0\\.03691091666039018\ \(0\)\
\-\ application\\:\\ 0\\.03679298347236643\ \(0\)\
\-\ beneficial\\:\\ 0\\.03679298347236643\ \(0\)\
\-\ crystals\\:\\ 0\\.03679298347236643\ \(0\)\
\-\ depend\\:\\ 0\\.03645889613096712\ \(0\)\
\-\ distinguishing\\:\\ 0\\.03584918551859496\ \(0\)\
\-\ as\\:\\ 0\\.03558850011784575\ \(0\)\
\-\ bursitis\\:\\ 0\\.03556930345912645\ \(0\)\
\-\ amorphous\\:\\ 0\\.03556930345912645\ \(0\)\
\-\ menisci\\:\\ 0\\.03556930345912645\ \(0\)\
\-\ region\\:\\ 0\\.035325784795612006\ \(0\)\
\-\ attack\\:\\ 0\\.035051215718688813\ \(0\)\
\-\ time\\:\\ 0\\.03500512481926803\ \(0\)\
\-\ depends\\:\\ 0\\.03435998283685408\ \(0\)\
\-\ natural\\:\\ 0\\.03435998283685408\ \(0\)\
\-\ an\\:\\ 0\\.03387533167939139\ \(0\)\
\-\ largely\\:\\ 0\\.03375027222448193\ \(0\)\
\-\ unresponsive\\:\\ 0\\.03375027222448193\ \(0\)\
\-\ opposed\\:\\ 0\\.033562013036947946\ \(0\)\
\-\ corticosteroid\\:\\ 0\\.033380360815370845\ \(0\)\
\-\ abduction\\:\\ 0\\.033204867496512525\ \(0\)\
\-\ over\\:\\ 0\\.03283880591516915\ \(0\)\
\-\ heat\\:\\ 0\\.03271148890620918\ \(0\)\
\-\ cppd\\:\\ 0\\.03271148890620918\ \(0\)\
\-\ exercises\\:\\ 0\\.032556953337129296\ \(0\)\
\-\ injections\\:\\ 0\\.032556953337129296\ \(0\)\
\-\ disability\\:\\ 0\\.032556953337129296\ \(0\)\
\-\ saunders\\:\\ 0\\.03226106954274106\ \(0\)\
\-\ bone\\:\\ 0\\.03222384769985895\ \(0\)\
\-\ pain\\:\\ 0\\.03169965151370039\ \(0\)\
\-\ stages\\:\\ 0\\.03158784209514448\ \(0\)\
\-\ rotator\\:\\ 0\\.03122228622446831\ \(0\)\
\-\ associated\\:\\ 0\\.031127958207385942\ \(0\)\
\-\ cuff\\:\\ 0\\.030992179136235726\ \(0\)\
\-\ varying\\:\\ 0\\.030992179136235726\ \(0\)\
\-\ can\\:\\ 0\\.030991731054456996\ \(0\)\
\-\ connective\\:\\ 0\\.030665129942928773\ \(0\)\
\-\ diagnosis\\:\\ 0\\.030615212679389027\ \(0\)\
\-\ affect\\:\\ 0\\.030560549474430102\ \(0\)\
\-\ left\\:\\ 0\\.03021892231642089\ \(0\)\
\-\ ages\\:\\ 0\\.030162156248628023\ \(0\)\
\-\ men\\:\\ 0\\.03006717088412675\ \(0\)\
\-\ spontaneously\\:\\ 0\\.03006717088412675\ \(0\)\
\-\ gout\\:\\ 0\\.02979224483951694\ \(0\)\
\-\ occurring\\:\\ 0\\.02979224483951694\ \(0\)\
\-\ borders\\:\\ 0\\.029703754528721586\ \(0\)\
\-\ core\\:\\ 0\\.029616751520658624\ \(0\)\
\-\ drugs\\:\\ 0\\.029531186644880095\ \(0\)\
\-\ densities\\:\\ 0\\.029531186644880095\ \(0\)\
\-\ radiographically\\:\\ 0\\.029447013129713217\ \(0\)\
\-\ ovoid\\:\\ 0\\.029447013129713217\ \(0\)\
\-\ experience\\:\\ 0\\.02936418644872188\ \(0\)\
\-\ mechanical\\:\\ 0\\.02928266417925931\ \(0\)\
\-\ severity\\:\\ 0\\.029123372930355277\ \(0\)\
\-\ facet\\:\\ 0\\.0286015516469325\ \(0\)\
\-\ 2002\\:\\ 0\\.028258607918215526\ \(0\)\
\-\ treatment\\:\\ 0\\.028132426100132477\ \(0\)\
\-\ hyperparathyroidism\\:\\ 0\\.028127548838917753\ \(0\)\
\-\ frequency\\:\\ 0\\.028063242954514993\ \(0\)\
\-\ cartilage\\:\\ 0\\.027999726119290577\ \(0\)\
\-\ elbow\\:\\ 0\\.02787498376698101\ \(0\)\
\-\ adults\\:\\ 0\\.02757567745536099\ \(0\)\
\-\ needle\\:\\ 0\\.027404063160381825\ \(0\)\
\-\ erosion\\:\\ 0\\.027404063160381825\ \(0\)\
\-\ year\\:\\ 0\\.027300737229530282\ \(0\)\
\-\ within\\:\\ 0\\.02720026173886174\ \(0\)\
\-\ 4th\\:\\ 0\\.027183750885146282\ \(0\)\
\-\ episodes\\:\\ 0\\.026972433498576198\ \(0\)\
\-\ destruction\\:\\ 0\\.02692092504250711\ \(0\)\
\-\ higher\\:\\ 0\\.026819420670241078\ \(0\)\
\-\ erythema\\:\\ 0\\.026719868426639454\ \(0\)\
\-\ women\\:\\ 0\\.026574040272774123\ \(0\)\
\-\ resolved\\:\\ 0\\.026526329731126678\ \(0\)\
\-\ lead\\:\\ 0\\.026294158213305618\ \(0\)\
\-\ become\\:\\ 0\\.026204128863663037\ \(0\)\
\-\ nature\\:\\ 0\\.026071954267256222\ \(0\)\
\-\ disorders\\:\\ 0\\.026071954267256222\ \(0\)\
\-\ appropriate\\:\\ 0\\.02594307066902619\ \(0\)\
\-\ aspiration\\:\\ 0\\.025817318158234643\ \(0\)\
\-\ degree\\:\\ 0\\.025817318158234643\ \(0\)\
\-\ though\\:\\ 0\\.02565426350885624\ \(0\)\
\-\ reaction\\:\\ 0\\.025120911305829746\ \(0\)\
\-\ distribution\\:\\ 0\\.025049013523321482\ \(0\)\
\-\ sarcoidosis\\:\\ 0\\.025013435671078596\ \(0\)\
\-\ idiopathic\\:\\ 0\\.02497810067296184\ \(0\)\
\-\ disorder\\:\\ 0\\.02497810067296184\ \(0\)\
\-\ worse\\:\\ 0\\.024737287154595236\ \(0\)\
\-\ apparent\\:\\ 0\\.024703781813517758\ \(0\)\
\-\ clinically\\:\\ 0\\.02453943286306385\ \(0\)\
\-\ 70\\:\\ 0\\.024380141614159825\ \(0\)\
\-\ femur\\:\\ 0\\.024225606045079937\ \(0\)\
\-\ rupture\\:\\ 0\\.023872522142455478\ \(0\)\
\-\ characteristic\\:\\ 0\\.023872522142455478\ \(0\)\
\-\ lumbar\\:\\ 0\\.02384415737491316\ \(0\)\
\-\ site\\:\\ 0\\.02381594718452792\ \(0\)\
\-\ features\\:\\ 0\\.023759983859746283\ \(0\)\
\-\ inflammation\\:\\ 0\\.02373222745477659\ \(0\)\
\-\ increase\\:\\ 0\\.02370461908467041\ \(0\)\
\-\ recurrent\\:\\ 0\\.02367715717875495\ \(0\)\
\-\ radiology\\:\\ 0\\.023649840191223192\ \(0\)\
\-\ al\\:\\ 0\\.023462554132204997\ \(0\)\
\-\ especially\\:\\ 0\\.02335849922917959\ \(0\)\
\-\ occurs\\:\\ 0\\.02328180809130846\ \(0\)\
\-\ appear\\:\\ 0\\.023256494803095117\ \(0\)\
\-\ initially\\:\\ 0\\.023156461600919838\ \(0\)\
\-\ et\\:\\ 0\\.023131752450785557\ \(0\)\
\-\ slightly\\:\\ 0\\.023034078663931208\ \(0\)\
\-\ progressive\\:\\ 0\\.02261601288780914\ \(0\)\
\-\ removal\\:\\ 0\\.022571578648248592\ \(0\)\
\-\ history\\:\\ 0\\.022563548428829853\ \(0\)\
\-\ reveals\\:\\ 0\\.022462133617573175\ \(0\)\
\-\ are\\:\\ 0\\.02240979875690345\ \(0\)\
\-\ radiographic\\:\\ 0\\.02190807243754557\ \(0\)\
\-\ commonly\\:\\ 0\\.02185001698278982\ \(0\)\
\-\ confirmed\\:\\ 0\\.02177360884834245\ \(0\)\
\-\ greater\\:\\ 0\\.021754681744534606\ \(0\)\
\-\ 40\\:\\ 0\\.02171703389041489\ \(0\)\
\-\ involvement\\:\\ 0\\.021372407236672223\ \(0\)\
\-\ knee\\:\\ 0\\.021166005525689806\ \(0\)\
\-\ involving\\:\\ 0\\.020683368276092837\ \(0\)\
\-\ location\\:\\ 0\\.020561918550073333\ \(0\)\
\-\ presentation\\:\\ 0\\.020327246883870182\ \(0\)\
\-\ although\\:\\ 0\\.02010275394502448\ \(0\)\
\-\ size\\:\\ 0\\.019994055838399777\ \(0\)\
\-\ swelling\\:\\ 0\\.019874438156351093\ \(0\)\
\-\ cases\\:\\ 0\\.019861316331518837\ \(0\)\
\-\ initial\\:\\ 0\\.019809159143432543\ \(0\)\
\-\ spine\\:\\ 0\\.019506792496444346\ \(0\)\
\-\ past\\:\\ 0\\.01922111686376393\ \(0\)\
\-\ patient\\:\\ 0\\.019208580077190895\ \(0\)\
\-\ between\\:\\ 0\\.019186490934496234\ \(0\)\
\-\ adjacent\\:\\ 0\\.019140680395485096\ \(0\)\
\-\ during\\:\\ 0\\.018703580612926186\ \(0\)\
\-\ tenderness\\:\\ 0\\.018518316251697604\ \(0\)\
\-\ years\\:\\ 0\\.018100860625687314\ \(0\)\
\-\ evaluation\\:\\ 0\\.018008419649108737\ \(0\)\
\-\ on\\:\\ 0\\.017836508780541504\ \(0\)\
\-\ appearance\\:\\ 0\\.017801868721254034\ \(0\)\
\-\ following\\:\\ 0\\.017714572265889364\ \(0\)\
\-\ all\\:\\ 0\\.017577889549835905\ \(0\)\
\-\ include\\:\\ 0\\.017569465533128183\ \(0\)\
\-\ however\\:\\ 0\\.01747769499371995\ \(0\)\
\-\ 10\\:\\ 0\\.01726703919027103\ \(0\)\
\-\ presented\\:\\ 0\\.017219620014797335\ \(0\)\
\-\ distal\\:\\ 0\\.017157062671915843\ \(0\)\
\-\ than\\:\\ 0\\.016739130908016278\ \(0\)\
\-\ more\\:\\ 0\\.016214560314978685\ \(0\)\
\-\ consistent\\:\\ 0\\.016011282874455253\ \(0\)\
\-\ acute\\:\\ 0\\.01597404129566632\ \(0\)\
\-\ increased\\:\\ 0\\.015967860331201223\ \(0\)\
\-\ tissue\\:\\ 0\\.015490229645207998\ \(0\)\
\-\ demonstrate\\:\\ 0\\.015351290625305974\ \(0\)\
\-\ large\\:\\ 0\\.014795477450487357\ \(0\)\
\-\ had\\:\\ 0\\.014712416233686252\ \(0\)\
\-\ up\\:\\ 0\\.014606866463223414\ \(0\)\
\-\ findings\\:\\ 0\\.014573728810169901\ \(0\)\
\-\ surgical\\:\\ 0\\.014352040392288289\ \(0\)\
\-\ female\\:\\ 0\\.014249087743516891\ \(0\)\
\-\ also\\:\\ 0\\.013889579017866045\ \(0\)\
\-\ has\\:\\ 0\\.013487970966970932\ \(0\)\
\-\ there\\:\\ 0\\.011749483667854622\ \(0\)\
\-\ not\\:\\ 0\\.011657333097139967\ \(0\)\
\-\ was\\:\\ 0\\.010291136772630372\ \(0\)\
\-\ this\\:\\ 0\\.010146684265099072\ \(0\)\
